Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
COVID-19 vaccines – VRBPAC makes recommendations for new monovalent vaccine composition
The FDA’s Vaccine and Related Biological Products Advisory Committee (VRBPAC) unanimously voted for the 2024-2025 formula of COVID-19 vaccines in the U.S to include a monovalent JN.1-lineage.
